HEALTHEQUITY, INC.

HealthEquity, Inc. announced its plan to release financial results for its third quarter of fiscal year 2027 after market close on Tuesday, December 1, 2026. Following the release, the company's management will host an investor conference call at 4:30 p.m. Eastern Time on the same day to discuss the results. Details for the conference call, including dial-in numbers and a webcast link, were provided. A replay will be accessible on the company's investor relations website.

HealthEquity, Inc. announced the appointment of Noémie Heuland, Chief Financial Officer of Moody's Corporation, to its Board of Directors, effective September 24, 2026. This appointment expands the Board to eleven members. Ms. Heuland will serve on the Audit and Risk Committee and the Cybersecurity and Technology Committee. The company noted that it paid approximately $146,519 to Moody's controlled subsidiaries in the fiscal year ended January 31, 2026, for ratings services and data sets, and expects to pay over $120,000 in the current fiscal year. Ms. Heuland will receive standard director compensation.

HealthEquity, Inc. announced its plan to release financial results for its second quarter of fiscal 2027 before the opening of regular stock market trading on Thursday, August 27, 2026. Following the release, the company will host a conference call for investors at 8:30 a.m. Eastern Time to discuss the results. Additionally, HealthEquity management plans to present and meet with investors at upcoming conferences, including the Wells Fargo Healthcare Conference, Baird Global Healthcare Conference, and Deutsche Bank Healthcare Summit in September 2026.

HealthEquity, Inc. held its 2026 Annual Meeting on June 25, 2026, where stockholders approved all five proposals presented. These proposals included the election of ten directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and the approval of the fiscal 2026 executive compensation on an advisory basis. Additionally, stockholders approved both the 2026 Employee Stock Purchase Plan and the Amended and Restated 2024 Equity Incentive Plan.

HealthEquity's Spring 2026 Healthcare Affordability Pulse reveals that 36% of Americans delayed or avoided medical care due to cost in the past six months, leading to worsened health outcomes and significant workforce productivity losses. The report indicates that financial preparedness for healthcare expenses has fallen from 50% to 42%. However, the research highlights the positive impact of Health Savings Accounts (HSAs), with 88% of HSA holders reporting that their accounts help them feel financially prepared and 43% more likely to find healthcare expenses affordable compared to non-HSA individuals.

HealthEquity, Inc. reported strong financial results for the three months ended April 30, 2026, with total revenue increasing by 7.2% to $354.6 million and net income rising by 28.8% to $69.4 million. Diluted earnings per share grew significantly to $0.82. The company also announced a substantial increase of $1.0 billion to its common stock repurchase authorization, having already repurchased $123.0 million during the quarter.

HealthEquity, Inc. reported strong financial results for its first quarter ended April 30, 2026, with net income increasing 29% to $69.4 million and revenue growing 7% to $354.6 million. The company also announced a 17% rise in Adjusted EBITDA to $164.5 million and a 19% increase in total HSA assets to $37.1 billion. Following these results, HealthEquity raised its fiscal year 2027 guidance and authorized an additional $1.0 billion for its common stock repurchase program, reflecting confidence in its long-term growth and cash generation.

HealthEquity, Inc. announced strong financial results for its first quarter ended April 30, 2026, alongside an increase of $1.0 billion to its share repurchase program. The company reported a 29% increase in net income to $69.4 million and a 7% rise in revenue to $354.6 million. Adjusted EBITDA grew 17% to $164.5 million, with margins expanding to 46%. The company also raised its fiscal 2027 outlook, reflecting confidence in its growth model and cash-generating power.

HealthEquity, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on Thursday, June 25, 2026, at 10:00 a.m. Mountain Time. Stockholders will vote on the election of ten directors, ratification of PricewaterhouseCoopers LLP as auditor, an advisory vote on executive compensation, and approval of the 2026 Employee Stock Purchase Plan and the Amended and Restated 2024 Equity Incentive Plan. The company reported strong fiscal year 2026 results, with revenue up 9% to $1.313 billion and net income increasing 123% to $215.2 million.

HEALTHEQUITY, INC. announced amendments to the employment agreements for its President and CEO, CFO, Founder, and other executives on May 5, 2026, enhancing their severance payments and benefits. These changes include increased severance for the CEO to 12 months base salary plus target cash bonus, with higher benefits if termination occurs within 18 months of a change in control. Other executives will receive 12 months base salary plus target cash bonus under change-in-control scenarios. Additionally, new vesting terms for equity awards granted after March 25, 2026, were approved, allowing for accelerated vesting of time-based restricted stock units and prorated vesting eligibility for performance-based units upon certain terminations.